TO THE EDITOR
I find it very ironic when someone from one profession tries to correct another profession.1 First of all, having wiped out all nursing degree programs,who is going to educate these now cost-effective RNs? Other ADN’s? We all know very well that education doesn’t work that way.
And what about nursing administration? It simply doesn’t work to place people in administration without appropriate training, nor does it work to place non-nurses in nursing administration. Montoya speaks of patients seen by physicians whose treatment could be safely and effectively left to the care of another discipline. In terms of the advanced practice nurse/nurse practitioner, it is largely accepted that the minimum entry level into safe practice is at the master’s degree level of education. It can’t be both ways.
I guarantee that if/when you are sick and in need of nursing care, you will want to have a smart nurse. Nurses can and do save lives every day through their knowledge of illness and the effects and side effects of medications. “Dumbing down” the nursing profession places patients at risk for injury and medication errors. The standard of excellence simply cannot be lowered. I have been in the nursing profession for 16 years and have on numerous occasions seen the unfortunate effects of substandard nursing care by substandard nurses. Trust me, it’s not something that you would want to receive. Having lowered the standard of practice in this way, where will the workforce come from? Potential nurses are already staying away from the profession by the thousands, due largely to the perceived lack of prestige associated with the profession.
Whenever talk of cost-containment arises, nursing care is one of the first activities to come under scrutiny. But what of the pharmaceutical and medical technology industries? Much of the healthcare budget goes to developing newer but marginally advantageous medications and cutting edge technological advancements designed to treat conditions that are largely preventable. Services are duplicated in competing hospitals, only for the sake of competition for the healthcare dollar, and yet costs are driven up for everyone.
During the Crimean War, Florence Nightingale demonstrated that appropriate nursing care, incorporating education in scientific principles, translated into saved lives. She did not invent or pioneer the profession, which has been around for hundreds ofyears, but she did reveal its potential. Since that time, the profession has continued to demonstrate this fact and to evolve according to the needs of the era. However, as with all symbiotic relationships, it is a very fragile one. In this day and age people have many other career choices and, with regards to nursing, they are demonstrating this fact. Nurses are subjected to work conditions that many other professions are not willing to tolerate. Long hours, mandatory overtime, and emotional and psychological distress are part and parcel of the nursing profession. When nursing is devalued, it creates an environment in which ruthless administrators feel justified in allowing substandard nursing care and inadequate staffing. This issue is currently being played out throughout the US. At its best, the nursing profession is not merely a technical job, but an embodiment of the best of human compassion. If we are willing to sacrifice this compassion in hopes of monetary gains, I am convinced that we all stand to pay a greater price than we can know.
Richard Frank, MSN, FNP
Bandon, OR
1. Montoya ID. Is the healthcare workforce a barrier to cost containment? Am J Manag Care 2000;6:971-972.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More